© 2002 by Gut
DYSPEPSIA MANAGEMENT
Use of antisecretory agents as a trial of therapy
Correspondence to:
Correspondence to:
Dr M B Fennerty, Division of Gastroenterology, OHSU, PV-310, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201-3098, USA;
fennerty{at}OHSU.edu
Dyspepsia is a common clinical condition, and its diagnostic evaluation and treatment result in the expenditure of enormous healthcare resources each year. Studies indicate that the omeprazole test is the most sensitive and cost effective test for diagnosing gastro-oesophageal reflux disease (GORD) in patients with extra-oesophageal or more "classic" symptoms suggestive of GORD. Studies also indicate that a therapeutic trial of omeprazole in patients with dyspepsia results in greater symptom improvement and lower costs than treatment with less potent acid suppression.
Keywords: dyspepsia; gastro-oesophageal reflux disease; H2 receptor antagonist; omeprazole; trial of therapy
Abbreviations: GORD; gastro-oesophageal reflux disease
Relevant Article
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Gut 2002 50: iv72-iv78.
This article has been cited by other articles:
-
Jones, M P
(2003). Evaluation and treatment of dyspepsia. Postgrad. Med. J.
79: 25-29
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
